$BFLY

DEVIVO JOSEPH sold $60K of BFLY

DEVIVO JOSEPH (President & CEO) sold 5,980 shares of Butterfly Network, Inc. (BFLY) at an average of $10.01 ($10.00–$10.02) across 2 trades over 2026-09-22 to 2026-09-23 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · DEVIVO JOSEPH
Published Sep 24, 2026, 9:50 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 24, 2026, 10:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BFLY
Neutral
high confidence
Mentioned
$BFLY
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BFLYNeutralLow
01

Why it matters

Minor sell unlikely to affect stock valuation; serves as routine disclosure.

02

Market read

Low relevance; small insider sale with limited market impact.

03

What to watch

Sale executed under 10b5-1 plan, reducing speculation about motive.

Relevance 2/10Novelty 4/10Timing: filed today

Background

Form 4 filing discloses insider transactions; investors monitor for material changes.

Company-level read

Ticker impact

$BFLYNeutralHigh confidence
Context

President & CEO sold ~60K of shares via 10b5-1 plan, reducing holdings to 7.35M shares.

Expected impact

No significant impact; price may stay flat.

Evidence & confidence

Sale size is small relative to float and disclosed via pre-arranged plan.

Market effects

None; insider activity does not affect medical imaging sector broadly.

None; company is US‑listed with limited regional relevance.

None; transaction is company‑specific and small.

Counterpoint

Insider sell could signal confidence in future performance despite reduction.

Key entities

  • Devivo Joseph

    President & CEO of Butterfly Network

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BFLYHighAI 8/10

Why is Butterfly Network stock surging today?

Butterfly Network (BFLY) stock rose 11.5% after Needham initiated coverage with a Buy rating and $10 target, citing its ultrasound tech and Embedded business model. TD Cowen also has a Buy rating and $10 target. BFLY's Q3 revenue grew 39% YoY, with Embedded segment growth and expanding margins. The broader market had minimal impact on BFLY's surge.

$BFLYMed

Butterfly Network at Morgan Stanley conference: platform push widens reach

Butterfly Network (BFLY) presented its strategy at Morgan Stanley's conference, shifting from handheld ultrasound to a semiconductor imaging platform. The company reported 20% revenue growth, with $112M in last 12-month revenue, and highlighted partnerships like Midjourney. It aims to expand its addressable market to $250B through its Butterfly Embedded model. The company expects a fourth-generation chip in 2027 to improve image quality and challenge competitors. Management emphasized its strong

$BFLYMed

Butterfly Network (BFLY) Is Up 24.2% After Raising 2026 Guidance And Narrowing Losses - Has The Bull Case Changed?

Butterfly Network (BFLY) shares rose 24.2% after the company reported Q2 2026 revenue of $32.61M and a reduced net loss of $12.91M, and raised 2026 revenue guidance to $119M to $123M. The article cites improving losses and momentum in Embedded partnerships and enterprise point-of-care ultrasound, while noting ongoing cash burn and potential dilution risks.

$BFLYMedAI 9/10

Butterfly (BFLY) Q2 2026 Earnings Call Transcript

Butterfly Network (BFLY) reported Q2 2026 revenue of $32.6M, up 39% y/y, driven by Embedded revenue of $10.8M (+439%). Gross profit rose to $23.3M and gross margin to 71%. Adjusted EBITDA loss narrowed to $1.4M. Q3 revenue guidance is $26M to $30M, and FY2026 revenue guidance is $119M to $123M.